These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 18377699)
21. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053 [TBL] [Abstract][Full Text] [Related]
22. ER regulates an evolutionarily conserved apoptosis pathway. Liu Z; Chen S Biochem Biophys Res Commun; 2010 Sep; 400(1):34-8. PubMed ID: 20691160 [TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor target gene: an evolving concept. Carroll JS; Brown M Mol Endocrinol; 2006 Aug; 20(8):1707-14. PubMed ID: 16396959 [TBL] [Abstract][Full Text] [Related]
24. Identification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data. Ding M; Wang H; Chen J; Shen B; Xu Z Comput Math Methods Med; 2012; 2012():568950. PubMed ID: 23346221 [TBL] [Abstract][Full Text] [Related]
26. Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition. Kinyamu HK; Collins JB; Grissom SF; Hebbar PB; Archer TK Mol Carcinog; 2008 Nov; 47(11):845-85. PubMed ID: 18381591 [TBL] [Abstract][Full Text] [Related]
27. New biology of the oestrogen receptor. Dowsett M; Ashworth A Lancet; 2003 Jul; 362(9380):260-2. PubMed ID: 12892953 [No Abstract] [Full Text] [Related]
28. To bind or not to bind--FoxA1 determines estrogen receptor action in breast cancer progression. Watters RJ; Benos PV; Oesterreich S Breast Cancer Res; 2012 Jun; 14(3):312. PubMed ID: 22713214 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer. Carroll JS Eur J Endocrinol; 2016 Jul; 175(1):R41-9. PubMed ID: 26884552 [TBL] [Abstract][Full Text] [Related]
36. Toward a transcriptional map of the human genome. Hochgeschwender U Trends Genet; 1992 Feb; 8(2):41-4. PubMed ID: 1566368 [No Abstract] [Full Text] [Related]
38. Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications. Etgen AM; Jover-Mengual T; Zukin RS Front Neuroendocrinol; 2011 Aug; 32(3):336-52. PubMed ID: 21163293 [TBL] [Abstract][Full Text] [Related]
39. Chromosome-wide analysis of protein binding and modifications. Sarge KD; Xing H; Park-Sarge OK Methods Mol Biol; 2009; 590():223-33. PubMed ID: 19763507 [TBL] [Abstract][Full Text] [Related]
40. The gad2 promoter is a transcriptional target of estrogen receptor (ER)alpha and ER beta: a unifying hypothesis to explain diverse effects of estradiol. Hudgens ED; Ji L; Carpenter CD; Petersen SL J Neurosci; 2009 Jul; 29(27):8790-7. PubMed ID: 19587286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]